TP53 and B-cell chronic lymphocytic leukemia: As shown in Figure 10, CLL cells carrying mutant p53 displayed a lower GSH content, irrespective of treatment, and significant differences were found compared to wt p53 carrying cells under every treatment condition (Figure 10).